Nutrisystem (NTRI) Cash Flow Statement

Click line-items for a historical chart and %

Net income	26.62M
Loss on discontinued operation
Depreciation and amortization	10.16M
(Gain) loss on disposal of fixed assets
Share-based compensation expense	5.13M
Deferred income tax benefit	1.61M
Loss on sales of marketable securities
Receivables	6.66M
Inventories, net	11.1M
Supplier advances, net
Other assets	3.29M
Accounts payable	-6.7M
Accrued payroll and related benefits	-273K
Deferred revenue	193K
Income taxes	-1.15M
Other accrued expenses and liabilities	-827K
Net cash provided by operating activities of continuing operations	55.92M
Net cash used in operating activities of discontinued operation
Net cash provided by operating activities
Purchases of marketable securities	-14.07M
Sales of marketable securities	4.05M
Capital additions	-10.44M
Proceeds from the sale of fixed assets
Net cash provided by (used in) investing activities of continuing operations	-20.46M
Net cash used in investing activities of discontinued operation
Net cash provided by (used in) investing activities
Exercise of stock options	1.84M
Taxes related to equity compensation awards, net
Payment of dividends	-15.59M
Repurchase and retirement of common stock
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents
NET INCREASE IN CASH AND CASH EQUIVALENTS	20.83M
CASH AND CASH EQUIVALENTS, beginning of period	6.19M
CASH AND CASH EQUIVALENTS, end of period	27.02M
LESS CASH AND CASH EQUIVALENTS OF DISCONTINUED OPERATION, end of period
CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period

Entities mentioned with ntri

View All Entities